Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market

MEA Extracorporeal Membrane Oxygenation Machine Market Size & Growth (2022 to 2027):

According to the report, the Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market Size is anticipated to grow at a 2.2% CAGR from 2022 to 2027 and it is estimated that the market is valued at USD 27.49 million in 2022 and is expected to reach USD 30.67 million by 2027.

The increase in the growing senior population and the number of individuals suffering from illnesses in populous nations are projected to provide significant growth prospects for expanding the extracorporeal membrane oxygenation machines as extracorporeal methods are used to give extended cardiac and respiratory support to people whose hearts and lungs cannot produce enough gas exchange or perfusion to preserve life. Also, the ECMO technique is primarily developed from cardiopulmonary bypass, which offers shorter-term assistance with the stopped native circulation, increasing the devices' market growth.

The growing incidence of cardiovascular and respiratory diseases with the conferences and training programs to raise awareness about the devices and treatments are accelerating the market growth during the forecast period. 

An increase in the new developments and technological advancements can also be attributed to the growth of the extracorporeal membrane oxygenation system market. 

Furthermore, the rise in the adoption of ECMO as a bridge to lung transplantation and an increase in the number of ECMO centers are driving the market growth majorly as asthma is a significant non-communicable illness. It is a chronic illness that causes inflammation and narrows the airways of the lungs. Therefore, earlier according to a World Health Organization estimate in 2017, roughly 235 million individuals worldwide have asthma. In adults, the global prevalence rates were increased by 4.3 percent as doctor-diagnosed asthma, 4.5 percent as clinical-treated asthma, and 8.6 percent as coughing, respectively, and varied by up to 21-fold across the 70 nations. 

Therefore, by the last 30 years, the survival rates for individuals with severe acute respiratory failure treated with ECMO have improved significantly. Also increase in the competition between the market players also plays an essential role in driving the market growth of the ECMO machine.

Increase in the high costs of the treatments and the therapies due to which people hesitate to undergo the procedures as well as due to lack of skilled individuals with the risks associated with the extracorporeal membrane oxygenation machines such as strokes, blood clots, infection, etc., are the standard and possible side effects of this machine can affect the market growth negatively.

This research report on the Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market has been segmented and sub-segmented into the following categories

By Modality:

• Veno-Arterial (VA)
• Veno-Venous (VV)
• Arterio-Venous (AV)

By Application:

• Respiratory
• Cardiac
• Extracorporeal Cardiopulmonary Resuscitation (ECPR)

By Country:

• KSA
• UAE
• Israel
• the rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the MEA is expected to grow at a lucrative pace extracorporeal membrane oxygenation machine market in the following years due to the increase in the prevalence of cardiovascular or breathing diseases with the rise in the senior population and the rise in the people in the region. 

South Africa extracorporeal membrane oxygenation machine market dominated the extracorporeal membrane oxygenation machine market, and it is likely to continue its domination throughout the forecast period. An increase in the initiative taken in healthcare expenditure by the government and non-government organizations to improve the medical and healthcare facilities is expected to drive the market growth. Also, as growth in new developments and advancements in the technology with the rise in the awareness and adoption of the extracorporeal membrane oxygenation machine will increase the market share. 

On the other hand, Saudi Arabia extracorporeal membrane oxygenation machine market and UAE extracorporeal membrane oxygenation machine market are anticipated to account for a considerable share in the extracorporeal membrane oxygenation machine market during the forecast period. The growing prevalence of chronic diseases, increasing healthcare expenditure, and supportive government policies propel market growth.

KEY MARKET PLAYERS

Companies dominating the Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market Profiled in the Report are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc., and EUROSETS S.r.l.